venBio
View Older Stories
-
Form SC 13D/A IMMUNOMEDICS INC Filed by: venBio Select Advisor LLC
-
Immunomedics Announces First Quarter Fiscal 2018 Results and Provides Corporate Update
-
Immunomedics Announces Fiscal 2017 Results and Strategic Developments; Reiterates Guidance on BLA Submission Timeline
-
Form SC 13D/A IMMUNOMEDICS INC Filed by: venBio Select Advisor LLC
-
Immunomedics (IMMU) Announces $125M Private Placement of Convertible Preferred Stock; Outlines Strategic Steps to Drive Stockholder Value; CEO to Step Down
-
Immunomedics Delivers Business Updates, Announces Private Placement Offering and Outlines Strategic Steps to Drive Stockholder Value
-
Form SC 13D/A IMMUNOMEDICS INC Filed by: venBio Select Advisor LLC
-
Stockholders Endorse venBio’s Case for Meaningful Change at Immunomedics
-
Immunomedics Board Institutes Measures As Stockholder Fiduciaries To Preserve Their Best Business Judgment To Protect The Rights Of All Stockholders
-
Form DFAN14A IMMUNOMEDICS INC Filed by: venBio Select Advisor LLC
-
venBio Encourages Stockholders to Vote for Change at Immunomedics (IMMU)
-
venBio Encourages Stockholders to Vote for Change
-
Immunomedics (IMMU) Says Revised Settlement Offer Rejected By venBio
-
Immunomedics Outlines Revised Settlement Offer Rejected By venBio; Announces Actions That Are In The Best Interests Of All Stockholders
-
Immunomedics Issues Open Letter Highlighting the Clear Decision to Vote for Immunomedics to Ensure Continued Value Creation
-
Form DFAN14A IMMUNOMEDICS INC Filed by: venBio Select Advisor LLC
-
venBio Sends Letter to Immunomedics Stockholders
-
Immunomedics Files Federal Lawsuit Against venBio for Continuing Material Violations of the Federal Securities Laws
-
Form SC 13D/A IMMUNOMEDICS INC Filed by: venBio Select Advisor LLC
-
Immunomedics Sends Letter to Stockholders Highlighting Value Creating Global Licensing Agreement, Underscoring Fulfillment of Promise to Stockholders
-
Immunomedics Comments on Baseless venBio Lawsuit
-
Form DFAN14A IMMUNOMEDICS INC Filed by: venBio Select Advisor LLC
-
venBio Takes Steps to Protect Immunomedics (IMMU) Stockholders Following Its Partnership with Seattle Genetics (SGEN)
-
venBio Takes Steps to Protect Rights of Immunomedics Stockholders
-
Form DFAN14A IMMUNOMEDICS INC Filed by: venBio Select Advisor LLC
-
venBio Comments on Immunomedics Partnership Announcement
-
Immunomedics Announces Second Quarter Fiscal 2017 Results and Clinical Program Developments
-
Form DFAN14A IMMUNOMEDICS INC Filed by: venBio Select Advisor LLC
-
Immunomedics Strongly Encourages Stockholders to Reject the venBio Nominees — With Four New Independent Directors and a Robust Value-Maximization Process, Stockholders Should Not Risk Giving venBio
-
Glass Lewis Endorses Full Slate of venBio Nominees at Immunomedics
-
Form DFAN14A IMMUNOMEDICS INC Filed by: venBio Select Advisor LLC
-
ISS Endorses Full Slate of venBio Nominees at Immunomedics
-
Immunomedics Mails Letter to Stockholders Highlighting Strength of New Board and Deep Engagement in Robust, Value-Creating Strategic and CMC Processes
-
Form DFAN14A IMMUNOMEDICS INC Filed by: venBio Select Advisor LLC
-
Form DFAN14A IMMUNOMEDICS INC Filed by: venBio Select Advisor LLC
-
Immunomedics Sets the Record Straight in New Presentation
-
venBio Calls on Immunomedics Stockholders to Support Meaningful Change
-
Immunomedics Issues Statement to Stockholders and Files Investor Presentation
-
Form DFAN14A IMMUNOMEDICS INC Filed by: venBio Select Advisor LLC
-
venBio Releases Presentation Detailing Urgent Case for Change at Immunomedics
-
Immunomedics Mails Letter to Stockholders
-
Form DFAN14A IMMUNOMEDICS INC Filed by: venBio Select Advisor LLC
-
venBio Sends Letter to Immunomedics Stockholders
-
Immunomedics to Mail Letter to Stockholders Highlighting Unprecedented Progress Toward Enhanced Value Creation
-
Form DFAN14A IMMUNOMEDICS INC Filed by: venBio Select Advisor LLC
-
Form DFAN14A IMMUNOMEDICS INC Filed by: venBio Select Advisor LLC
-
venBio Sends Letter to Immunomedics Stockholders
-
Form DFAN14A IMMUNOMEDICS INC Filed by: venBio Select Advisor LLC
-
venBio Responds to Immunomedics Announcement
-
Immunomedics Announces Reconstituted Board of Directors and Leadership Succession Plan